Nunes Anne 4
4 · Anika Therapeutics, Inc. · Filed Oct 4, 2024
Insider Transaction Report
Form 4
Nunes Anne
SVP, Chief Operations Officer
Transactions
- Exercise/Conversion
Common Stock
2024-10-01+2,491→ 14,211 total - Exercise/Conversion
Restricted Stock Unit
2024-10-01−2,491→ 0 totalExercise: $0.00→ Common Stock (2,491 underlying) - Tax Payment
Common Stock
2024-10-01$24.27/sh−732$17,766→ 13,479 total
Footnotes (5)
- [F1]Reflects the third and final vesting installment of RSUs granted on October 1, 2021.
- [F2]Includes 634 shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan on May 14, 2024.
- [F3]Reflects an aggregate of 732 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on October 1, 2024.
- [F4]Reflects the closing price of ANIK common stock on October 1, 2024, the trading day on which the vesting of RSUs gave rise to tax withholding obligations.
- [F5]Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning October 1, 2022.